Valvular & structural heart disease

Quality of Life After Transcatheter Tricuspid Valve Repair: Results from the Tri.FR Trial

ESC Heart FailPublished randomized

Authors' conclusion

Compared with OMT alone, T-TEER resulted in substantial, multidimensional, and sustained improvements in patient-reported quality of life. These findings reinforce the value of T-TEER in managing severe symptomatic TR.

Study context

Population
Patients with severe symptomatic tricuspid regurgitation (TR) in the Tri.FR trialrandomized to tricuspid transcatheter edge-to-edge repair (T-TEER) +OMT (n = 152) or OMT alone (n = 148)
Participants
152 vs 148
Comparison
T-TEER + OMT vs OMT alone
  • T-TEER +OMTn = 152
  • OMT alonen = 148

Primary result

As reported in the abstract

Change in Kansas City Cardiomyopathy Questionnaire (KCCQ) overall summary score (KCCQ-OS) in T-TEER + OMT

KCCQ-OS change at 6 weeks

+17.0 points (95% confidence interval [CI] 13.1-21.5)

KCCQ-OS change at 6 months

+15.9 points

95% CI 11.2–20.6

KCCQ-OS change at 1 year

+18.7 points

95% CI 13.8–23.6

Further findings

OutcomeMean between-group difference (points) (95% CI)
MLHF total scoreT-TEERvs OMT aloneImproved significantly in the T-TEER group−8.61 (−12.6 to −4.6)
OutcomeEstimate
KCCQ-OS, mean between-group difference · evident at 6 weeks and sustained for 1 yearIn favour of T-TEER + OMTmean between-group difference +10.3 points (95% CI 5.6–15.0)
MLHF total scoreT-TEER vs OMT alonephysical subscale −3.9 (95% CI −5.9 to −1.9)
MLHF total scoreT-TEER vs OMT aloneemotional subscale −2.2 (95% CI −3.4 to −1.0)

Original publication

Quality of Life After Transcatheter Tricuspid Valve Repair: Results from the Tri.FR Trial. ESC Heart Fail. Published 19 May 2025. doi:10.1002/ehf2.15327

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.